Gaining Ground: Adverum Biotechnologies Inc (ADVM) Closes Lower at 2.91, Down -2.02

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

The price of Adverum Biotechnologies Inc (NASDAQ: ADVM) closed at $2.91 in the last session, down -2.02% from day before closing price of $2.97. In other words, the price has decreased by -$2.02 from its previous closing price. On the day, 1.04 million shares were traded.

Ratios:

We take a closer look at ADVM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.73 and its Current Ratio is at 5.73. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.22.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on June 25, 2024, initiated with a Outperform rating and assigned the stock a target price of $25.

On April 30, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $30.

Truist Upgraded its Hold to Buy on July 07, 2022, while the target price for the stock was maintained at $4.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 22 ’25 when Leonard Braden Michael bought 300,000 shares for $3.00 per share. The transaction valued at 900,000 led to the insider holds 3,057,526 shares of the business.

Leonard Braden Michael bought 50,000 shares of ADVM for $148,950 on Apr 23 ’25. The 10% Owner now owns 191,800 shares after completing the transaction at $2.98 per share. On Mar 31 ’25, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 19,566 shares for $4.38 each. As a result, the insider paid 85,668 and bolstered with 2,742,317 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 60.79 while its Price-to-Book (P/B) ratio in mrq is 0.86.

Stock Price History:

Over the past 52 weeks, ADVM has reached a high of $10.98, while it has fallen to a 52-week low of $2.71. The 50-Day Moving Average of the stock is -29.45%, while the 200-Day Moving Average is calculated to be -50.83%.

Shares Statistics:

A total of 20.85M shares are outstanding, with a floating share count of 13.92M. Insiders hold about 33.35% of the company’s shares, while institutions hold 60.61% stake in the company.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.